Economic burden of gastro-oesophageal reflux disease and dyspepsia: A community-based study

Arab Journal of Gastroenterology

Volumn 12, Issue 2, 2011, Pages 86-89

  Moghimi Dehkordi, Bijan ^a   Vahedi, Mohsen ^a   Khoshkrood Mansoori, Babak ^a   Kasaeian, Amir ^b   Safaee, Azadeh ^a   Habibi, Manijeh ^a   Pourhoseingholi, Asma ^a   Pourhoseingholi, Mohammad Amin ^a   Zali, Mohammad Reza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cost analysis; Dyspepsia; Economic burden; Gastro oesophageal reflux disease; Iran

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DYSPEPSIA; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HOSPITALIZATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL;

ADULT; AGED; COST OF ILLNESS; DYSPEPSIA; EFFICIENCY; GASTROESOPHAGEAL REFLUX; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; IRAN; MALE; MIDDLE AGED; OFFICE VISITS; PREVALENCE; QUESTIONNAIRES;

EID: 79959280290     PISSN: 16871979     EISSN: 20902387     Source Type: Journal    
DOI: 10.1016/j.ajg.2011.03.005     Document Type: Article

References (30)

1. Brook R.A., Wahlqvist P., Kleinman N.L., et al. Cost of gastro-oesophageal reflux disease to the employer: a perspective from the united states. Alimen Pharmacol Therap 2007, 26(6):889-898.
2. Dean B.B., Crawley J.A., Schmitt C.M., et al. The burden of illness of gastro-oesophageal reflux disease: impact on work productivity. Aliment Pharmacol Ther 2003, 17(10):1309-1317.
3. Rezailashkajani M., Roshandel D., Shafaee S., et al. High prevalence of reflux oesophagitis among upper endoscopies of Iranian patients. Eur J Gastroenterol Hepatol 2007, 19(6):499-506.
4. Poelmans J., Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut 2005, 54(10):1492-1499.
5. Ruigómez A., García Rodríguez L.A., Wallander M.A., et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Alimen Pharmacol Therap 2004, 20(7):751-760.
6. Fass R. Epidemiology and pathophysiology of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003, 98(Suppl 3):S2-7.
7. Gisbert JP, Cooper A, Karagiannis D et al. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Quality Life Outcomes 2009;7: Art. no. 60.
8. Henke C.J., Levin T.R., Henning J.M., et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000, 95(3):788-792.
9. Joish V.N., Donaldson G., Stockdale W., et al. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 2005, 21(4):535-544.
10. Wahlqvist P., Brook R.A., Campbell S.M., et al. Objective measurement of work absence and on-the-job productivity: a case-control study of US employees with and without gastroesophageal reflux disease. J Occupat Environ Med 2008, 50(1):25-31.
11. Colin Jones D.G., Bloom B., Bodemar G., et al. Management of dyspepsia: report of a working party. Lancet 1988, 1(8585):576-579.
12. Barbara L., Camilleri M., Corinaldesi R., et al. Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci 1989, 34(8):1272-1276.
13. Talley N.J., Stanghellini V., Heading R.C., et al. Functional gastroduodenal disorders. Gut 1999, 45(Suppl 2):II37-42.
14. Bytzer P., Talley N.J. Dyspepsia. Ann Intern Med 2001, 134(9 Pt 2):815-822.
15. Stanghellini V. Review article: pain versus discomfort - is differentiation clinically useful?. Aliment Pharmacol Ther 2001, 15(2):145-149.
16. Mahadeva S., Goh K.L. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006, 12(17):2661-2666.
17. Rezailashkajani M., Roshandel D., Shafaee S., et al. A cost analysis of gastro-oesophageal reflux disease and dyspepsia in Iran. Dig Liver Dis 2008, 40(6):412-417.
18. Willich S.N., Nocon M., Kulig M., et al. Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther 2006, 23(3):371-376.
19. Schwenkglenks M., Marbet U.A., Szucs T.D. Epidemiology and costs of gastroesophageal reflux disease in Switzerland: a population-based study. Soz Praventivmed 2004, 49(1):51-61.
20. Agreus L., Borgquist L. The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden. Pharmacoeconomics 2002, 20(5):347-355.
21. Barzkar M., Pourhoseingholi M.A., Habibi M., et al. Uninvestigated dyspepsia and its related factors in an Iranian community. Saudi Med J 2009, 30(3):397-402.
22. Khoshkrood Mansoori B., Pourhoseingholi M.A., Safaee A., et al. Irritable bowel syndrome: a population based study. J Gastrointest Liver Dis 2009, 18(4):413-418.
23. Pourhoseingholi A., Pourhoseingholi M.A., Vahedi M., et al. Relation between demographic factors and hospitalization in patients with gastrointestinal disorders, using quantile regression analysis. East Afr J Public Health 2009, 6(Suppl.1):45-47.
24. Pourhoseingholi M.A., Kaboli S.A., Pourhoseingholi A., et al. Obesity and functional constipation; a community-based study in Iran. J Gastrointest Liver Dis 2009, 18(2):151-155.
25. Pourhoseingholi M.A., Vahedi M., Moghimi Dehkordi B., et al. Burden of hospitalization for gastrointestinal tract cancer patients - results from a cross-sectional study in Tehran. Asian Pac J Cancer Prev 2009, 10(1):107-110.
26. Solhpour A., Pourhoseingholi M.A., Soltani F., et al. Gastro-esophageal reflux symptoms and body mass index: no relation among the Iranian population. Indian J Gastroenterol 2008, 27(4):153-155.
27. Solhpour A., Pourhoseingholi M.A., Soltani F., et al. Gastro-oesophageal reflux disease and irritable bowel syndrome: a significant association in an Iranian population. Eur J Gastroenterol Hepatol 2008, 20(8):719-725.
28. Sorouri M., Pourhoseingholi M.A., Vahedi M., et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol 2010, 16(3):154-160.
29. Roshandel D., Rezailashkajani M., Shafaee S., et al. A cost analysis of functional bowel disorders in Iran. Int J Colorectal Dis 2007, 22(7):791-799.
30. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 2002, 122(5):1500-1511.